Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-08-10 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AIX EN PROVENCE (13080), Bouches-du-Rhone
PHARMACIE DU VAL SAINT ANDRE : revenue, balance sheet and financial ratios
PHARMACIE DU VAL SAINT ANDRE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AIX EN PROVENCE (13080),
this company of category PME
shows in 2018 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU VAL SAINT ANDRE (SIREN 813002987)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 164 614 €
2 203 071 €
Net income
-36 374 €
70 360 €
91 111 €
135 739 €
100 736 €
85 592 €
64 448 €
46 252 €
87 545 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
87 807 €
123 238 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2.1%
4.0%
Revenue and income statement
In 2025, PHARMACIE DU VAL SAINT ANDRE records a net loss of 36 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-36 374 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 624%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
623.893%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
12.396%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU VAL SAINT ANDRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
204.03
170.234
144.66
118.697
91.793
67.599
53.163
42.436
623.893
Financial autonomy
29.074
32.802
36.507
40.047
46.5
52.057
57.177
62.202
12.396
Repayment capacity
11.2
16.436
None
None
None
None
None
None
None
Cash flow / Revenue
4.594%
2.88%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
623.892025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch+32 pts over 3 years
In 2025, the debt ratio of PHARMACIE DU VAL SAINT ANDRE (623.89) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
12.4%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch-36 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU VAL SAINT ANDRE (12.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 252.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
252.532
Liquidity indicators evolution PHARMACIE DU VAL SAINT ANDRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
127.521
107.095
99.432
114.475
111.554
112.827
104.773
87.763
252.532
Interest coverage
10.537
13.462
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
252.532025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+53 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU VAL SAINT ANDRE (252.53) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU VAL SAINT ANDRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
134 321 €
170 637 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
25
26
0
0
0
0
0
0
0
Customer payment term (days)
4
4
129
0
0
0
0
0
0
Supplier payment term (days)
33
36
672
0
0
0
0
0
0
Positioning of PHARMACIE DU VAL SAINT ANDRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU VAL SAINT ANDRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU VAL SAINT ANDRE
What is the revenue of PHARMACIE DU VAL SAINT ANDRE ?
The revenue of PHARMACIE DU VAL SAINT ANDRE in 2018 is 2.2 M€.
Is PHARMACIE DU VAL SAINT ANDRE profitable?
PHARMACIE DU VAL SAINT ANDRE recorded a net loss in 2025.
Where is the headquarters of PHARMACIE DU VAL SAINT ANDRE ?
The headquarters of PHARMACIE DU VAL SAINT ANDRE is located in AIX EN PROVENCE (13080), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE DU VAL SAINT ANDRE ?
The tax return of PHARMACIE DU VAL SAINT ANDRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU VAL SAINT ANDRE operate?
PHARMACIE DU VAL SAINT ANDRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart